Therapy-Specific Biomarkers

Small Molecules / Tyrosine Kinase Inhibitors (TKI’s)

• Gleevec (Imatinib)
  
• Iressa (Gefitinib)
  

Monoclonal Antibodies

• Herceptin (Trastuzumab)
• KRAS
• Erbitux (Cetuximab)
• Vectibix (panitumumab)

Chemotherapy

• Xeloda (Capecitabine) / 5-FU
• Topoisomerase Inhibitors

To consult with TMD’s Translational Biomarker Specialists, call 866.897.7350 ex 213 or email TMD Translational Biomarker Services at biomarkers@tmdlab.com.